mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.17 |
0.002 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.17 |
0.003 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.003 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.006 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.008 |